Prostate Cancer - Results from #25220

Inflammation and prostate carcinogenesis - Abstract September 1, 2012

The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancer - Abstract September 1, 2012

Impact of pre-implant lower urinary tract symptoms on postoperative urinary morbidity after permanent prostate brachytherapy - Abstract September 1, 2012

FDA approves Xtandi (enzalutamide) September 1, 2012

Long term results of a prospective dose escalation phase-II trial: Interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer - Abstract August 31, 2012

A novel measure of dietary change in a prostate cancer dietary program incorporating mindfulness training - Abstract August 31, 2012

Evaluation of physician eye lens doses during permanent seed implant brachytherapy for prostate cancer - Abstract August 31, 2012

Practice patterns in the management of prostate cancer in Spain: Results from a national survey among radiation oncologists in 2009 - Abstract August 31, 2012

Evaluation of the association of prostate cancer-specific anxiety with sexual function, depression and cancer aggressiveness in men 1 year following surgical treatment for localized prostate cancer - Abstract August 31, 2012

Effect of prostate-specific antigen screening on metastatic disease burden 10 years after diagnosis - Abstract August 31, 2012

Effect of body mass index on intrafraction prostate displacement monitored by real-time electromagnetic tracking - Abstract August 31, 2012

Advanced prostate cancer treated with intermittent or continuous androgen deprivation in the Randomised FinnProstate Study VII: Quality of life and adverse effects - Abstract August 31, 2012

Presidential Proclamation -- National Prostate Cancer Awareness Month, 2012 August 31, 2012

Multidisciplinary care and pursuit of active surveillance in low-risk prostate cancer - Abstract August 31, 2012

Sorafenib in progressive castrate-resistant prostate cancer. Can we talk about a new therapeutic option? - Abstract August 31, 2012

The impact of obesity on the predictive accuracy of PSA in men undergoing prostate biopsy - Abstract August 30, 2012

Prostate-specific antigen screening for prostate cancer and the risk of overt metastatic disease at presentation: Analysis of trends over time - Abstract August 30, 2012

Can a Gleason 6 or less microfocus of prostate cancer in one biopsy and prostate-specific antigen level August 30, 2012

Hypofractionated proton boost combined with external beam radiotherapy for treatment of localized prostate cancer - Abstract August 30, 2012

Antibody-based detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases: ERG staining in prostate core biopsies - Abstract August 30, 2012

Page 1262 of 1451